These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26384263)

  • 1. Workplace drug testing on urine samples: evidence for improving efficacy of a first-level screening programme.
    Crespi V; Maio RC; Veronesi G; Gianfagna F; Taborelli S; Ferrario MM
    Med Lav; 2015 Sep; 106(5):374-85. PubMed ID: 26384263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Workplace drug testing in Italy: findings about second-stage testing.
    Vignali C; Stramesi C; Morini L; San Bartolomeo P; Groppi A
    Drug Test Anal; 2015 Mar; 7(3):173-7. PubMed ID: 24652693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of drug abuse among workers: strengths and pitfalls of the recent Italian Workplace Drug Testing (WDT) legislation.
    Kazanga I; Tameni S; Piccinotti A; Floris I; Zanchetti G; Polettini A
    Forensic Sci Int; 2012 Feb; 215(1-3):46-50. PubMed ID: 21482052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Workplace drug testing in Italy - critical considerations.
    Vignali C; Stramesi C; Morini L; Pozzi F; Collo G; Groppi A
    Drug Test Anal; 2013 Apr; 5(4):208-12. PubMed ID: 23355251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicators.
    Fraser AD; Zamecnik J
    Ther Drug Monit; 2003 Dec; 25(6):723-7. PubMed ID: 14639059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creatinine normalization of workplace urine drug tests: does it make a difference?
    Price JW
    J Addict Med; 2013; 7(2):129-32. PubMed ID: 23370934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A snapshot of workplace drug testing in Italy.
    Santoro PE; De Nardis I; Fronterrè P; Felli M; Martello S; Bergamaschi A; Chiarotti M
    Drug Test Anal; 2012 Feb; 4(2):66-70. PubMed ID: 22362571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Professional drivers and psychoactive substances consumption: results from medical surveillance at the workplace in Piedmont region].
    Rosso GL; Feola M; Rubinetto MP; Petti N; Rubinetto L
    G Ital Med Lav Ergon; 2011; 33(3 Suppl):203-6. PubMed ID: 23393836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of tools, methods and results of toxicological screening for detection of drug abuse in Italian professional drivers].
    Rosso GL
    Med Lav; 2013; 104(1):30-43. PubMed ID: 23520885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine drug testing for social service agencies in Nova Scotia, Canada.
    Fraser AD
    J Forensic Sci; 1998 Jan; 43(1):194-6. PubMed ID: 9456542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hair and urine testing to assess drugs of abuse consumption in couples undergoing assisted reproductive technology (ART).
    Pichini S; De Luca R; Pellegrini M; Marchei E; Rotolo MC; Spoletini R; D'Aloja P; Pacifici R; Mortali C; Scaravelli G
    Forensic Sci Int; 2012 May; 218(1-3):57-61. PubMed ID: 22018744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation of normal urine with a creatinine concentration under the cutoff of 20 mg/dL for specimen validity testing in a toxicology laboratory.
    Holden B; Guice EA
    J Forensic Sci; 2014 May; 59(3):806-10. PubMed ID: 24502684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of creatinine reference value: Normalization of urinary drug concentrations.
    Aydoğdu M; Oral S; Akgür SA
    J Forensic Sci; 2021 Sep; 66(5):1855-1861. PubMed ID: 33904587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
    Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
    Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary evaluations of drug consumption among workers having high risk of accident: technical difficulties, limits and possibilities of increasing efficacy of the law].
    D'Orso MI; Grosso D; Colli M; Gironi A; Riva MA; Cesana G
    G Ital Med Lav Ergon; 2012; 34(3 Suppl):756-8. PubMed ID: 23405771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: a collaborative study.
    Marquet P; Delpla PA; Kerguelen S; Bremond J; Facy F; Garnier M; Guery B; Lhermitte M; Mathé D; Pelissier AL; Renaudeau C; Vest P; Seguela JP
    J Forensic Sci; 1998 Jul; 43(4):806-11. PubMed ID: 9670503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests.
    Musshoff F; Driever F; Lachenmeier K; Lachenmeier DW; Banger M; Madea B
    Forensic Sci Int; 2006 Jan; 156(2-3):118-23. PubMed ID: 16410161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creatinine in urine - a method comparison.
    Luginbühl M; Weinmann W
    Drug Test Anal; 2017 Oct; 9(10):1537-1541. PubMed ID: 28102586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.